APA (7th ed.) Citation

Hofheinz, R., Kubicka, S., Wollert, J., Arnold, D., & Hochhaus, A. (2006). Gefitinib in combination with 5-Fluorouracil (5-FU)/ Folinic Acid and Irinotecan in patients with 5-FU/ Oxaliplatin refractory colorectal cancer: A Phase I/II Study of the Arbeitsgemeinschaft für Internistische Onkologie (AIO) / R.-D. Hofheinz; S. Kubicka; J. Wollert; D. Arnold; A. Hochhaus. Onkologie, 29(12), 563. https://doi.org/10.1159/000096449

Chicago Style (17th ed.) Citation

Hofheinz, Ralf-Dieter, Stefan Kubicka, Jörg Wollert, Dirk Arnold, and Andreas Hochhaus. "Gefitinib in Combination with 5-Fluorouracil (5-FU)/ Folinic Acid and Irinotecan in Patients with 5-FU/ Oxaliplatin Refractory Colorectal Cancer: A Phase I/II Study of the Arbeitsgemeinschaft Für Internistische Onkologie (AIO) / R.-D. Hofheinz; S. Kubicka; J. Wollert; D. Arnold; A. Hochhaus." Onkologie 29, no. 12 (2006): 563. https://dx.doi.org/10.1159/000096449.

MLA (8th ed.) Citation

Hofheinz, Ralf-Dieter, et al. "Gefitinib in Combination with 5-Fluorouracil (5-FU)/ Folinic Acid and Irinotecan in Patients with 5-FU/ Oxaliplatin Refractory Colorectal Cancer: A Phase I/II Study of the Arbeitsgemeinschaft Für Internistische Onkologie (AIO) / R.-D. Hofheinz; S. Kubicka; J. Wollert; D. Arnold; A. Hochhaus." Onkologie, vol. 29, no. 12, 2006, p. 563.

Warning: These citations may not always be 100% accurate.